Table 1.
TAU (n=49) |
CBT (n=94) |
ISP (n=97) |
|
---|---|---|---|
Age M (SD) | 47·1 (8·7) | 48·6 (8·0) | 46·5 (8·6) |
Gender n (%) | |||
Male | 36 (73·5) | 72 (76·6) | 57 (58·8) |
Female | 13 (26·5) | 22 (23·4) | 40 (41·2) |
Race n* | |||
African American/Black | 14 | 26 | 28 |
Caucasian/White | 31 | 63 | 62 |
Other | 7 | 10 | 14 |
Hispanic/Latino n (%) | |||
Yes | 7 (14·3) | 7 (7·4) | 12 (12·4) |
No | 42 (85·7) | 87 (92·6) | 85 (87·6) |
Education n (%) | |||
Partial high school or less | 9 (18·4) | 11 (11·7) | 13 (13·4) |
High school graduate | 12 (24·5) | 25 (26·6) | 28 (28·9) |
Partial college | 14 (28·6) | 32 (34) | 24 (24·7) |
College graduate | 14 (28·6) | 26 (27·7) | 32 (33) |
On Disability n (%) | |||
Yes | 32 (65·3) | 55 (58·5) | 52 (53·6) |
No | 17 (34·7) | 39 (41·5) | 45 (46·4) |
Sexual Orientation n (%) | |||
Exclusively homosexual | 26 (53·1) | 29 (30·9) | 26 (26·8) |
Homosexual with some heterosexual experience | 3 (6·1) | 22 (23·4) | 17 (17·5) |
Bisexual | 2 (4·1) | 4 (4·3) | 8 (8·2) |
Heterosexual with some homosexual experience | 3 (6·1) | 9 (9·6) | 6 (6·2) |
Exclusively heterosexual | 15 (30·6) | 30 (31·9) | 40 (41·2) |
MEMs based adherence | 71.29 (24.43) | 72.33 (22.69) | 71.77 (25.53) |
Clinical Global Impression (CGI) M (SD) | 4.51 (1.16) | 4.33 (1.26) | 4.67 (1.14) |
MADRS M (SD) | 24.33 (7.95) | 23.48 (8.04) | 26.86 (8.30) |
CESD M (SD) | 29.33 (8.36) | 26.31 (6.80) | 27.42 (7.71) |
CD4 M (SD) | 560.33 (256.88) | 585.44 (284.28) | 578.26 (275.40) |
Viral Load (log 10) M (SD) | 1.96 (0.26) | 2.14 (0.73) | 1.98 (0.48) |
Detectable viral load, proportion | .15 | .17 | .11 |
Race category not mutually exclusive, as participants could choose more than one category. Ns for viral load (47, 92, 92), CD4 (48, 91, 92), and MEMs (49, 92, 94) for ETAU, CBT-AD and ISP-AD respectively are lower than the other measures due to issues with lab processing or user/technology issues with starting MEMs.